期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

体外循环围术期炎性介质水平改变的临床意义

下载PDF
导出
摘要 体外循环（CPB）时血液直接接触非生理性物质表面、非生理性灌注、手术创伤、器官缺血再灌注、内毒素释放等均可触发全身炎症反应综合（SIRS）。机体在全身炎症反应发生的同时代偿性抗炎反应也伴随发生，二者相辅相成；促炎、抗炎性细胞因子能调节机体炎症反应和抗炎反应之间的动态平衡，是炎症反应的重要介质。我们对本院CPB心脏手术患者围术期血清炎性介质水平进行了动态监测，以探究其在CPB围术期患者监护工作中的指导意义。
作者 牛新荣
机构地区 新疆维吾尔自治区人民医院外科ICU
出处 《新疆医学》 2009年第12期19-22,共4页 Xinjiang Medical Journal
关键词 血清炎性介质 围术期患者 体外循环 临床意义 CPB心脏手术 全身炎症反应 机体炎症反应 抗炎性细胞因子
分类号 R657.51 [医药卫生—外科学] R473.6 [医药卫生—护理学]
  • 相关文献

参考文献8

  • 1Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthe - siology, 2002,97 ( 1 ) : 215 - 252.
  • 2武婷,文其祥.体外循环过程中的炎性反应机制及治疗策略[J].中国体外循环杂志,2004,2(1):56-60. 被引量：10
  • 3Hirai S. Systemic innammatory response syndrome after cardiac surgery under cardiopulmonary bypass. Ann Thorae Cardiovasc Surg,2003,9 (6) : 365 - 370.
  • 4Kim YI,Song KE, Ryeon HK, et al. Enhanced innammatory cytokiner roduction at ischemia/reperfusion in humanliver resection. Hepatogastroenterology, 2002, 49(46) : 1077 - 1082.
  • 5SablotzkiA, Mann V, Simm A, et al. Changes in the Cytokine network through escalating SIRS after heart surgery. Anasthesiol Intensivmed Noffallmed Schmerzther,2001,36(9) :552 - 559.
  • 6Harmon D,Coleman E,Marshall C ,et al. The effect of clomethiazole onplasma concentrations of interleukin - 6, - 8, - 1 beta, tumor necrosis factoralpha, and neutrophil adhesion molecule expression duhng experimental extracorporeal circulation. Anesth Analg, 2003,97 ( 1 ) : 13 - 18.
  • 7Giomarelli P, Seolletta S, Borrelli E, et al. Myocardial and lung injury after cardiopulmonary bypass: role of interleukin ( IL ) - 10. Ann Thorac Surg, 2003,76 (1) :117 -123.
  • 8Rothenburger M, Tjan TD, Schneider M, et al. The impact of the proand antiinnammatory immune response on ventilation time after cardiac surgery. Cytometry, 2003,53B( 1 ) :70 - 74.

二级参考文献32

  • 1[21]Chermoff AE,Granowitz EV,Shapiro L,et al.The inflammatory response and extracorporeal circulation[J].J Cardiothorac Vasc Anethesia,1997,11(5):575.
  • 2[22]Hiyama A,Takeda J,Kotate Y,et al.A human urinary protease inhibitor(ulinastatin)inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass[J].J Cardiothorac Vasc Anesth,1997,11:580-584.
  • 3[23]Nilsson G,Costa JJ,Metcalf DD.Mast cells and basophils.In Gallin JI,Snyderman R eds.Inflammation.Basic principles and clinical correlates[M].Lippincott Williams&Wilkins,1999,102.
  • 4[24]Tayama E,Hayashida N,Fukunaga S,et al.High-dose cimetidine reduces proinflammatory reaction after cardiac surgery with cardiopulmonary bypass[J].Ann Thorac Surg 2001,72:1945-1949.
  • 5[25]Brull DJ,Sanders J,Rumley A,et al.Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release[J].Heart 2002,87:252-255.
  • 6[26]Akera T,Brody TM.Drugs to treat heart failure:cardiac glycosides.In Brody TM,Larner J,Minneman KP eds.Human pharmacology[J].St Louis,MO:Mosby,1998,218-219.
  • 7[27]Bach F,Grundmann U,Bauer M,et al.Modulation of the inflammatory response to cardiopulmonary bypass by dopexamine and epidural anesthesia[J].Acta anaesthesiol Scand 2002,46:1227-1235.
  • 8[28]Edmunds LH Jr.Blood-surface interactions during cardiopulmonary bypass[J].J Card Surg 1993,8:404-410.
  • 9[29]Grossi EA,Kallenbach K,Chau S,et al.Impact of heparin bonding on pediatric cardiopulmonary bypass:a prospective randomized study[J].Ann Thorac Surg,2000,70:191-196.
  • 10[30]Thomas M H,Heinz M L,Hugo V A,et al.Milrinone modulates endotoxemia,systemin inflammation,and subsequent acute phase response after cardiopulmonary bypass[J].Anesthesiology,1999,90:72-79.

共引文献9

新疆医学
2009年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部